eJHaem Publication and MATRON Audit Spotlight Gaps in Pulmonary Embolism Care for Pregnant Patients
Giulia Simini, Haematology Resident at at University College London (UCL), has shared a post on Linkedin:
“New publication out in eJHaem:
‘Physician Survey on the Management of Pulmonary Embolism in Pregnancy: Need for Guidance and Training’
Our survey reveals significant challenges in managing pulmonary embolism (PE) during pregnancy —an area where uncertainty remains high. Key takeaways include:
- A pressing need for high-quality, real-world data on the management of intermediate- and high-risk PE in pregnancy
- Significant gaps in clinician training and limited access to advanced therapies
- Wide variability in clinical practice and perceptions of the usefulness of advanced interventions
- Uneven distribution and underutilization of Pulmonary Embolism Response Teams (PERTs)
In direct response to these findings, we launched MATRON – a national, multicenter audit focused on the management of high-risk and intermediate-high-risk PE in pregnancy.
By capturing real-world data across the UK, MATRON aims to fill critical evidence gaps and lay the groundwork for future clinical guidance. Results from first round of data collection will be shared soon.
A huge thank you to our collaborators and all the clinicians who contributed to this work.”
You can check the MATRON webpage here
Title: Physician Survey on the Management of Pulmonary Embolism in Pregnancy: Need for Guidance and Training
Authors: Giulia Simini, Richard Buka, Daniel Kajita, Omar Mukhlif, HaemSTAR collaborators, Gill Swallow, Pip Nicolson, Sajida Kazi
Read the full article here.
Stay informed with Hemostasis Today.
-
Nov 4, 2025, 09:26Courtney Lawrence: One of Our Most Popular American Red Cross SUCCESS Talks is Just Around the Corner!
-
Nov 4, 2025, 09:21New Study by Emmanuel J Favaloro and Team Questions Consistency in APS Classification and Diagnosis
-
Nov 4, 2025, 09:20Yazan Abou Ismail to Present Insights on AI Models in TTP at 67th ASH Annual Meeting
-
Nov 4, 2025, 09:17David Calvet Canut on Takeda's HyHub: A Shift Toward Patient-Centered Biologics
-
Nov 4, 2025, 09:16Samantha Nelson Encourages You to Share Your Experience on World Thrombosis Day
-
Nov 4, 2025, 08:57Toluwalase Awoyemi: Digital Health Meets Maternal Heart Care
-
Nov 4, 2025, 08:53Rebecca Ahrens Nicklas Shares FDA Interactions on Interventional Genetics with The Rare Disease Community
-
Nov 3, 2025, 09:13Claudio Carrubba on How Timing Truly Matters in Trauma Embolization
-
Nov 3, 2025, 08:57Multiplex Apolipoprotein Panel Boosts Cardiovascular Risk Prediction and Precision Therapy
-
Nov 3, 2025, 08:46Rachel Lamerton and Colleagues on Activation of Platelets in Flow Cytometry
-
Nov 4, 2025, 09:10OCCUPI Trial Analysis Highlights Benefits of OCT Guidance in ACS Patients
-
Oct 29, 2025, 07:31The Use of Artificial Intelligence to Improve Detection of Acute Incidental Pulmonary Emboli - JTH
-
Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
-
Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
-
Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
-
Nov 4, 2025, 09:17HaemophiliaIRL Series Begins․ Advances in von Willebrand Disease Treatment
-
Nov 4, 2025, 09:14Exploring Molecular Pathways of Aging in Hematopoiesis․ FEBS Workshop 2025
-
Nov 4, 2025, 08:28Fritz Roth Thanks Supporters of Science Magazine Study Linking Genes to High Cholesterol and Heart Attack Risk
-
Nov 4, 2025, 08:22Colleen Silk on Novo Nordisk Taking the 2025 Prix Galien US Award
-
Nov 4, 2025, 08:14Cristina Anton: Excited to Be Part of Women in Hematology!